RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eckert & Ziegler Strahlen und Medizintechnik - Stock

Eckert & Ziegler Strahlen und Medizintechnik EBIT 2024

Eckert & Ziegler Strahlen und Medizintechnik EBIT

54.04 M EUR

Ticker

EUZ.DE

ISIN

DE0005659700

WKN

565970

In 2024, Eckert & Ziegler Strahlen und Medizintechnik's EBIT was 54.04 M EUR, a 22.26% increase from the 44.2 M EUR EBIT recorded in the previous year.

The Eckert & Ziegler Strahlen und Medizintechnik EBIT history

YEAREBIT (undefined EUR)
2026e62.52
2025e60.8
2024e54.04
202344.2
202242.12
202130.39
202028.74
201929.53
201820.01
201715.5
201611.85
20155.93
201411.27
201311.9
201219.8
201122.8
201018.5
200919.9
200811.6
20076
20065.9
20052.5
20043.4

Eckert & Ziegler Strahlen und Medizintechnik Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Eckert & Ziegler Strahlen und Medizintechnik, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eckert & Ziegler Strahlen und Medizintechnik from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eckert & Ziegler Strahlen und Medizintechnik’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Eckert & Ziegler Strahlen und Medizintechnik. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Eckert & Ziegler Strahlen und Medizintechnik’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Eckert & Ziegler Strahlen und Medizintechnik’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eckert & Ziegler Strahlen und Medizintechnik’s growth potential.

Eckert & Ziegler Strahlen und Medizintechnik Revenue, Profit, and EBIT History

DateEckert & Ziegler Strahlen und Medizintechnik RevenueEckert & Ziegler Strahlen und Medizintechnik EBITEckert & Ziegler Strahlen und Medizintechnik Net Income
2026e324.56 M undefined62.52 M undefined52.11 M undefined
2025e296.69 M undefined60.8 M undefined42.53 M undefined
2024e270.23 M undefined54.04 M undefined36.95 M undefined
2023246.09 M undefined44.2 M undefined26.3 M undefined
2022222.23 M undefined42.12 M undefined29.28 M undefined
2021180.44 M undefined30.39 M undefined34.53 M undefined
2020176.14 M undefined28.74 M undefined21.29 M undefined
2019178.49 M undefined29.53 M undefined22.02 M undefined
2018168.71 M undefined20.01 M undefined16.13 M undefined
2017138.63 M undefined15.5 M undefined14.7 M undefined
2016137.94 M undefined11.85 M undefined9.55 M undefined
2015139.75 M undefined5.93 M undefined10.72 M undefined
2014127.26 M undefined11.27 M undefined6.78 M undefined
2013117.1 M undefined11.9 M undefined9.1 M undefined
2012120 M undefined19.8 M undefined10.3 M undefined
2011116.2 M undefined22.8 M undefined10.4 M undefined
2010111.1 M undefined18.5 M undefined9.4 M undefined
2009101.4 M undefined19.9 M undefined13.3 M undefined
200871.6 M undefined11.6 M undefined4.5 M undefined
200755 M undefined6 M undefined1.9 M undefined
200650.4 M undefined5.9 M undefined2.2 M undefined
200541.8 M undefined2.5 M undefined1.6 M undefined
200435.5 M undefined3.4 M undefined3.3 M undefined

Eckert & Ziegler Strahlen und Medizintechnik stock margins

The Eckert & Ziegler Strahlen und Medizintechnik margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eckert & Ziegler Strahlen und Medizintechnik. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eckert & Ziegler Strahlen und Medizintechnik.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Eckert & Ziegler Strahlen und Medizintechnik's sales revenue. A higher gross margin percentage indicates that the Eckert & Ziegler Strahlen und Medizintechnik retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Eckert & Ziegler Strahlen und Medizintechnik's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Eckert & Ziegler Strahlen und Medizintechnik's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eckert & Ziegler Strahlen und Medizintechnik's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eckert & Ziegler Strahlen und Medizintechnik. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eckert & Ziegler Strahlen und Medizintechnik's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Eckert & Ziegler Strahlen und Medizintechnik Margin History

Eckert & Ziegler Strahlen und Medizintechnik Gross marginEckert & Ziegler Strahlen und Medizintechnik Profit marginEckert & Ziegler Strahlen und Medizintechnik EBIT marginEckert & Ziegler Strahlen und Medizintechnik Profit margin
2026e47.28 %19.26 %16.06 %
2025e47.28 %20.49 %14.33 %
2024e47.28 %20 %13.67 %
202347.28 %17.96 %10.69 %
202248.04 %18.95 %13.17 %
202150.48 %16.84 %19.14 %
202049.13 %16.32 %12.09 %
201948.75 %16.55 %12.34 %
201844.14 %11.86 %9.56 %
201746.07 %11.18 %10.6 %
201647.94 %8.59 %6.92 %
201544.98 %4.24 %7.67 %
201450.12 %8.86 %5.32 %
201346.29 %10.16 %7.77 %
201252.17 %16.5 %8.58 %
201153.7 %19.62 %8.95 %
201050.86 %16.65 %8.46 %
200950.39 %19.63 %13.12 %
200847.77 %16.2 %6.28 %
200749.82 %10.91 %3.45 %
200647.42 %11.71 %4.37 %
200544.26 %5.98 %3.83 %
200445.92 %9.58 %9.3 %

Eckert & Ziegler Strahlen und Medizintechnik Aktienanalyse

What does Eckert & Ziegler Strahlen und Medizintechnik do?

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler Strahlen und Medizintechnik ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Eckert & Ziegler Strahlen und Medizintechnik's EBIT

Eckert & Ziegler Strahlen und Medizintechnik's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Eckert & Ziegler Strahlen und Medizintechnik's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Eckert & Ziegler Strahlen und Medizintechnik's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Eckert & Ziegler Strahlen und Medizintechnik’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Eckert & Ziegler Strahlen und Medizintechnik Stock

How much did Eckert & Ziegler Strahlen und Medizintechnik achieve in EBIT for the current year?

In the current year, Eckert & Ziegler Strahlen und Medizintechnik has achieved an EBIT of 54.04 M EUR.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Eckert & Ziegler Strahlen und Medizintechnik.

How has the EBIT of Eckert & Ziegler Strahlen und Medizintechnik developed in recent years?

The EBIT of Eckert & Ziegler Strahlen und Medizintechnik has increased by 22.257% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Eckert & Ziegler Strahlen und Medizintechnik?

The EBIT of Eckert & Ziegler Strahlen und Medizintechnik is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Eckert & Ziegler Strahlen und Medizintechnik pay?

Over the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.14 %. For the coming 12 months, Eckert & Ziegler Strahlen und Medizintechnik is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler Strahlen und Medizintechnik?

The current dividend yield of Eckert & Ziegler Strahlen und Medizintechnik is 1.14 %.

When does Eckert & Ziegler Strahlen und Medizintechnik pay dividends?

Eckert & Ziegler Strahlen und Medizintechnik pays a quarterly dividend. This is distributed in the months of July, July, June, July.

How secure is the dividend of Eckert & Ziegler Strahlen und Medizintechnik?

Eckert & Ziegler Strahlen und Medizintechnik paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler Strahlen und Medizintechnik?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.24 %.

In which sector is Eckert & Ziegler Strahlen und Medizintechnik located?

Eckert & Ziegler Strahlen und Medizintechnik is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler Strahlen und Medizintechnik kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler Strahlen und Medizintechnik from 7/1/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Eckert & Ziegler Strahlen und Medizintechnik pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Eckert & Ziegler Strahlen und Medizintechnik in the year 2023?

In the year 2023, Eckert & Ziegler Strahlen und Medizintechnik distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler Strahlen und Medizintechnik pay out the dividend?

The dividends of Eckert & Ziegler Strahlen und Medizintechnik are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eckert & Ziegler Strahlen und Medizintechnik stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eckert & Ziegler Strahlen und Medizintechnik

Our stock analysis for Eckert & Ziegler Strahlen und Medizintechnik Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Strahlen und Medizintechnik Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.